Consolidated Statements of Cash Flows

QIAGEN Key figures 2012

 

  • Main Image Navi
Years ended December 31 
$ 1,000
2016 2015
Cash flows from operating activities:     
Net income 80,303
129,902
Adjustments to reconcile net income to net cash provided by operating activities, net of effects of businesses acquired:
 
 
Depreciation and amortization 213,056
191,473
Non-cash acquisition, impairment and restructuring related costs  44,399
5,471
Amortization of debt discount and issuance costs 20,451 19,955
Share-based compensation expense 28,288
23,760
Excess tax benefits from share-based compensation (782)
(3,328)
Deferred income taxes (65,974)
(36,434)
Loss on early redemption of debt    -                                             7,564
(Gain) Loss on marketable securities (1,360)                                            6,039
Changes in fair value of contingent consideration (6,501)
(5,225)
Other items, net including fair value changes in derivatives 19,435
2,609
Net changes in operating assets and liabilities:
 
 
Accounts receivable (12,238)
(24,764)
Inventories (20,346)
(33,194)
Prepaid expenses and other current assets 6,640                                           52,315
Other long-term assets 3,549
2,730
Accounts payable (1,466)
7,732
Accrued and other liabilities 10,618
(25,570)
Income taxes 15,476
(88)
Other long-term liabilities 8,054
(3,450)
Net cash provided by operating activities 341,602
317,497
Cash flows from investing activities:     
Purchases of property, plant and equipment 74,536
(97,778)
Proceeds from sale of equipment 63
103
Purchases of intangible assets (19,388)
(19,703)
Purchases of investments (23,448)
(6,053)
Purchases of short-term investments (496,304)
(317,570)
Proceeds from sales of short-term investments 533,847
367,714
Cash paid for acquisitions, net of cash acquired (90,490)
(66,930)
Other investing activities (8,800) (5,983)
Net cash used in investing activities (179,056)
(146,200)
Cash flows from financing activities:     
Purchase of call option related to cash convertible notes   -     - 
Proceeds from issuance of warrants, net of issuance costs   -      -  
Net proceeds from issuance of cash convertible notes and cash paid for issuance costs   -   (86)
Repayment of long-term debt (6,738)
(251,868)
Principal payments on capital leases (1,322)
(1,079)
Proceeds from subscription receivables  -  
97
Excess tax benefits from share-based compensation 782
3,328
Proceeds from issuance of common shares 6,269
10,316
Purchase of treasury shares   -   (20,818)
Other financing activities (9,595)
1,497
Net cash used in financing activities (10,604)
(258,613)
Effect of exchange rate changes on cash and cash equivalents (2,773)
(15,340)
Net increase (decrease) in cash and cash equivalents 149,169
(102,656)
Cash and cash equivalents, beginning of period 290,011
392,667
Cash and cash equivalents, end of period 439,180
290,011 
Supplemental cash flow disclosures:
 
 
Cash paid for interest 18,227
20,799
Cash paid for income taxes 22,670
34,441
Supplemental disclosure of non-cash investing and financing activities:
 
 
Equipment purchased through capital lease 113
231
Intangible assets acquired in non-monetary exchange  -   5,900